Medi Schwall Pharma Private Limited, a active private limited company, was established on 19 August 2019 in Aurangabad, Maharashtra, India. Engaging in manufacturing within the food and beverages sector, it holds CIN: U24304MH2019PTC329435. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Syed Aman Asrar Quadri (Director), Syed Asrar Viqaroddin Quadri (Director), Mohammed Abdul Mateen Mohammed Abdul Bari Siddiqui (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.17 Gut No. 84 Latif Nagar Deolai Parisar, Aurangabad, Maharashtra, 431001.
U24304MH2019PTC329435
329435
19 August 2019
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Medi Schwall Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Syed Aman Asrar Quadri | Director | 10 May 2023 | Current |
| Syed Asrar Viqaroddin Quadri | Director | 19 Aug 2019 | Current |
| Mohammed Abdul Mateen Mohammed Abdul Bari Siddiqui | Director | 19 Aug 2019 | Current |
| Tahura Asrar Quadri | Director | 30 Sep 2025 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medi Schwall Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 924.87% increase. The company also saw a substantial improvement in profitability, with a 239.65% increase in profit. The company's net worth Soared by an impressive increase of 321.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Medi Schwall Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Medi Schwall Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medi Schwall Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medi Schwall Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Tahura Asrar Quadri was appointed as a Director was appointed as a Director on 30 Sep 2025 & has been associated with this company since 2 months 28 days . was recorded as a recent event.
Medi Schwall Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Medi Schwall Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Syed Aman Asrar Quadri was appointed as a Director was appointed as a Director on 10 May 2023 & has been associated with this company since 2 years 7 months . was recorded as a recent event.
The activity Syed Asrar Viqaroddin Quadri was appointed as a Director was appointed as a Director on 19 Aug 2019 & has been associated with this company since 6 years 4 months . was completed.
The activity Mohammed Abdul Mateen Mohammed Abdul Bari Siddiqui was appointed as a Director was appointed as a Director on 19 Aug 2019 & has been associated with this company since 6 years 4 months . was completed.
The CIN of Medi Schwall Pharma Private Limited is U24304MH2019PTC329435.
Medi Schwall Pharma Private Limited is headquartered at Plot No.17 Gut No. 84 Latif Nagar Deolai Parisar, Aurangabad, Maharashtra, 431001.
Medi Schwall Pharma Private Limited was incorporated on 19 August 2019.
The current directors of Medi Schwall Pharma Private Limited are
The primary industry of Medi Schwall Pharma Private Limited is Food And Beverages.
Medi Schwall Pharma Private Limited is unlisted.
The authorized capital of Medi Schwall Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX